Progress in gene therapy offers hope for long-term knee pain relief

For nearly three decades, Mayo Clinic researcher Christopher Evans, Ph.D., has pushed to expand gene therapy beyond its original scope of fixing rare, single-gene defects. That has meant systematically advancing the field through laboratory experiments, pre-clinical studies and clinical trials.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup